The Oncology QCARD Initiative: Fostering efficient evaluation of initial real-world data proposals.

Autor: Rivera DR; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Eckert JC; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Rodriguez-Watson C; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Lerro CC; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Bertagnolli MM; Alliance for Clinical Trials in Oncology, Brigham & Women's Hospital, Boston, Massachusetts, USA., Hubbard RA; Department of Biostatistics, Epidemiology & Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kushi LH; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA., Lund JL; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Schrag D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Wang SV; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Wood WA; Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Lee JJ; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Okafor C; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Ghauri K; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Winckler SC; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Kluetz PG; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Publikováno v: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Nov; Vol. 33 (11), pp. e5818.

Conscientious objection and collaborative practice: conflicting or complementary initiatives?

Autor: Winckler SC; American Pharmacists Association, Washington, DC 20037-2985, USA. swinckler@aphanet.org, Gans JA

Publikováno v: Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2006 Jan-Feb; Vol. 46 (1), pp. 12-3.

Pharmacist services: insurance need not be the only answer.

Autor: Winckler SC; American Pharmaceutical Association, Washington, DC, USA.

Publikováno v: Journal of the American Pharmaceutical Association (Washington, D.C. : 1996) [J Am Pharm Assoc (Wash)] 2002 Nov-Dec; Vol. 42 (6), pp. 826.

The role of pharmacy computer systems in preventing medication errors.

Autor: Chrischilles EA; Department of Epidemiology, College of Public Health, University of Iowa, Iowa City 52242, USA. e-chrischilles@uiowa.edu, Fulda TR, Byrns PJ, Winckler SC, Rupp MT, Chui MA

Publikováno v: Journal of the American Pharmaceutical Association (Washington, D.C. : 1996) [J Am Pharm Assoc (Wash)] 2002 May-Jun; Vol. 42 (3), pp. 439-48.

The future of compounding: an industry perspective.

Autor: Capps S; IJPC, Edmond, OK., Jackson RA, Winckler SC, Tribble P, Anthony CJ, Halperin JA

Publikováno v: International journal of pharmaceutical compounding [Int J Pharm Compd] 2000 May-Jun; Vol. 4 (3), pp. 204-5.